ConductScience.org, home

Paper23331

Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).

Goldsmith LA. Exp Cell Biol, 1978. Cited by 29 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome). Papers, record 23331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23331

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).
PubMed
Journal
Exp Cell Biol
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.29
iCite
Revised in PubMed
2019-10-27
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goldsmith LAL A

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amino Acid Metabolism, Inborn ErrorsMajor topic
Eye DiseasesMajor topic
Skin DiseasesMajor topic
TyrosineMajor topic
Tyrosine TransaminaseMajor topic
Animals
Child
Crystallization
Disease Models, Animal
Female
Hemolysis
Heterozygote
Humans
In Vitro Techniques
Infant
Infant, Newborn
Intellectual Disability
Liver
Lysosomes
Male
Rats
Syndrome

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
36471409The mutation spectrum and ethnic distribution of non-hepatorenal tyrosinemia (types II, III).Orphanet J Rare Dis2022https://conductscience.org/library/papers/36471409PubMed
33578033Amino acid metabolism and autophagy in skeletal development and homeostasis.Bone2021https://conductscience.org/library/papers/33578033PubMed
29417439Antioxidants Reverse the Changes in the Cholinergic System Caused by L-Tyrosine Administration in Rats.Neurotox Res2018https://conductscience.org/library/papers/29417439PubMed
28315992Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II.Metab Brain Dis2017https://conductscience.org/library/papers/28315992PubMed
6117279Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II.Biochem Genet1981https://conductscience.org/library/papers/6117279PubMed
3516355Metabolic syndromes with dermatologic manifestations.Clin Rev Allergy1986https://conductscience.org/library/papers/3516355PubMed
1350979Maternal tyrosinaemia II: management and successful outcome.Eur J Pediatr1992https://conductscience.org/library/papers/1350979PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23331

GET https://conductscience.org/api/papers/v1/23331/authors